Blar i HiØ Brage på tidsskrift "Research and Practice in Thrombosis and Haemostasis"

Viser treff 1-3 av 3

    • Fatigue after initiating rivaroxaban for venous thromboembolism 

      Karlsvik, Tina Margrethe; Borgenvik, Thore Langfeldt; Aadalen, Mirjam; Utne, Kristin Kornelia; Førsund, Eli; Jørgensen, Camilla Tøvik; Holst, René; Jelsness-Jørgensen, Lars-Petter; Ghanima, Waleed Khalid (Peer reviewed; Journal article, 2020-03-09)
      Background Rivaroxaban was the first new oral anticoagulant approved for treatment of venous thromboembolism (VTE). Clinical trials have shown that rivaroxaban is noninferior to conventional anticoagulation for VTE in ...

    • Fatigue after initiating rivaroxaban for venous thromboembolism 

      Karlsvik, Tina Margrethe; Borgenvik, Thore Langfeldt; Aadalen, Mirjam; Utne, Kristin Kornelia; Førsund, Eli; Jørgensen, Camilla Tøvik; Holst, René; Jelsness-Jørgensen, Lars-Petter; Ghanima, Waleed Khalid (Peer reviewed; Journal article, 2020-03-09)
      Background. Rivaroxaban was the first new oral anticoagulant approved for treatment of venous thromboembolism (VTE). Clinical trials have shown that rivaroxaban is noninferior to conventional anticoagulation for VTE in ...

    • Health-related quality-of-life questionnaires for deep vein thrombosis and pulmonary embolism: A systematic review on questionnaire development and methodology 

      Asady, Elia; Ghanima, Waleed; Jelsness-Jørgensen, Lars-Petter; Klok, F. A.; Kahn, Susan R.; Strømme, Hilde; Wik, Hilde Skuterud (Peer reviewed; Journal article, 2021)
      To improve the quality and accuracy of the patient-reported outcome measures that assess health-related quality of life (HRQoL), guidelines have been developed to standardize the development and validation process. Considering ...